Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$939K Sell
968
-121
-11% -$107K 2.8% 1
2023
Q4
$824K Hold
1,089
2.64% 3
2023
Q3
$641K Sell
1,089
-1
-0.1% -$664 2.4% 15
2023
Q2
$790K Sell
1,090
-1
-0.1% -$680 2.67% 5
2023
Q1
$743K Sell
1,091
-28
-3% -$18K 2.69% 6
2022
Q4
$611K Sell
1,119
-34
-3% -$17.8K 1.5% 28
2022
Q3
$479K Buy
1,153
+4
+0.3% +$2K 1.11% 37
2022
Q2
$547K Hold
1,149
1.1% 36
2022
Q1
$767K Buy
1,149
+1
+0.1% +$670 1.01% 29
2021
Q4
$914K Buy
+1,148
New +$912K 1.06% 28

Other funds holding ASML

Merlin Capital's ASML Position: Q1 2024 in Review

Merlin Capital reduced its ASML (ASML) stake by 11% in Q1 2024, selling an estimated $107K and leaving 968 shares worth $939K. The position accounts for 2.8% of the portfolio, ranked #1.

Merlin Capital first reported a position in ASML in Q4 2021 and has held it in 10 quarters since. 1,492 funds tracked by Wall St. Rank hold ASML as of Q1 2024.

  • Merlin Capital held 968 shares of ASML worth $939K as of Q1 2024.
  • Merlin Capital sold 121 ASML shares in Q1 2024, an estimated $107K.
  • ASML made up 2.8% of Merlin Capital's portfolio in Q1 2024, its #1 holding.
  • Merlin Capital first reported a position in ASML in Q4 2021 and has held it in 10 quarters since.
  • 1,492 funds tracked by Wall St. Rank held ASML as of Q1 2024.

Based on Merlin Capital's 13F filing for Q1 2024, filed 13 May 2024.